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ABSTRACT
The human cytomegalovirus protein pUL69 belongs
to a family of regulatory factors that is conserved
within the Herpesviridae and includes the proteins
ICP27 of herpes simplex virus type 1 and EB2 of
Epstein–Barr virus. ICP27 and EB2 have been shown
tofacilitatethenuclearexportofviralmRNAsviainter-
acting with the cellular mRNA export factor REF.
Furthermore, direct RNA-binding of these proteins
was found to be essential for their stimulating effects
on mRNA export. Recently, we demonstrated that
pUL69 shares common features with ICP27 and EB2
suchas(i)nucleocytoplasmicshuttlingand(ii)stimu-
lationofnuclearRNAexportviabindingtothecellular
mRNA export machinery. Here, we demonstrate
that pUL69 can also interact with RNA both in vivo
and in vitro via a complex N-terminal RNA-binding
domain consisting of three arginine-rich motifs.
Interestingly,theRNA-bindingdomainofpUL69over-
laps with both the NLS and the binding site of the
cellular mRNA export factors UAP56 and URH49.
While the deletion of the UAP56/URH49-binding site
abolished pUL69-mediated RNA export, an RNA-
binding deficient pUL69 mutant which still interacts
with UAP56/URH49 retained its RNA export activity.
This surprising finding suggests that, in contrast
to its homologues, RNA-binding is not a prerequisite
for pUL69-mediated nuclear RNA export.
INTRODUCTION
One of the characteristic features of eukaryotes is the spatial
and temporal separation of gene transcription and mRNA
translation by the nuclear membrane. These essential cellular
processes are connected by the mRNA export pathway.
Currently, the majority of metazoan mRNAs appears to be
exported to the cytoplasm by the heterodimeric TAP-p15
transport receptor (1–4). Although TAP is able to interact
directly with cellular RNA in vitro in a sequence-non-
speciﬁc fashion, several lines of evidence suggest that addi-
tional factors are needed to bridge the interaction between
TAP and mRNA in vivo (5). Proteins that function as adaptors
between mRNAs and TAP-p15 have been identiﬁed. Among
these areseveralRNA-bindingproteinsandinparticularmem-
bers of the REF protein family. REF proteins shuttle between
the nucleus and the cytoplasm and bind directly to both mRNA
and TAP (6). Another important mRNA export factor is the
putative DExD/H-box RNA helicase UAP56 which has been
implicated in the recruitment of REF onto mRNAs (7,8).
Recently, a protein with >90% amino acid identity to
UAP56, termed URH49, has been identiﬁed in mammalian
cells and is supposed to have similar functions to UAP56 (9).
Both REF and UAP56 additionally interact with components
of the splicing machinery thus coupling splicing to mRNA
export. This has been proposed as a mechanism to enhance the
nuclear export of RNAs derived from spliced genes (10,11).
While most metazoan mRNAs undergo splicing, viruses
often contain intronless genes (e.g. herpesviruses) or are
dependent on the nuclear export and translation of unspliced
messages(e.g. retroviruses).As a consequence, several viruses
that replicate in the nucleus have evolved transactivator pro-
teins to promote the nuclear export of otherwise inefﬁciently
exported viral mRNAs via utilizing distinct nuclear export
pathways (12,13). For instance, complex retroviruses like
HIV-1 encode sequence-speciﬁc RNA-binding proteins such
as HIV-1 Rev to recruit the CRM-1 nuclear export receptor
onto incompletely spliced and unspliced viral RNAs to facili-
tate their nuclear export (14). In contrast, herpesviruses
express a group of homologous regulatory proteins which
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RNAs by exploiting components of the cellular mRNA export
pathway (13).
The best-characterized herpesviral mRNA export factor is
the protein ICP27, which is encoded by the alpha-herpesvirus
herpes simplex virus type 1 (HSV-1). It has been demonstrated
that ICP27 recruits the adaptor protein REF and hence
the mRNA export receptor TAP onto a set of intronless viral
mRNAs thus recruiting these transcripts to the cellular mRNA
export pathway (15–18). Additionally, a direct interaction
between ICP27 and TAP has been detected recently (16). Sub-
sequently, it was described that several homologues of ICP27
encoded by members of the gamma-herpesvirus subgroup
could also bind to REF suggesting a conserved mechanism
of herpesviral mRNA export. An interaction with REF was
detected for the Epstein–Barr virus (EBV) protein EB2 (19),
the Kaposi’s sarcoma-associated herpesvirus (KSHV) protein
ORF57(20)andtheHerpesvirussaimiri(HVS)proteinORF57
(21). In addition to protein contacts with REF, a direct RNA-
binding activity of some of these herpesviral mRNA export
factors was found to be essential for their stimulatory effects
onmRNAexport,suggestingthattheyserveasadaptorproteins
bridging the interaction between viral mRNA, REF and hence
the TAP-p15 exporter (18,22).
Human cytomegalovirus, the prototype of the beta-
herpesvirus subfamily, also encodes a transactivator protein
with homology to ICP27, termed pUL69 (23). The UL69 pro-
tein is a tegument phosphoprotein (24) which was ﬁrst
described as a pleiotropic transactivator of both viral and cel-
lular gene expression (23). Recently, we reported that pUL69
shares several activities with its herpesviral homologues such
as (i) nucleocytoplasmic shuttling activity (25) (ii) the ability
to promote the nuclear export of unspliced mRNA and (iii)
binding to cellular proteins involved in mRNA export (26).
However, in contrast to ICP27, EB2 and ORF57, pUL69 was
not able to bind to REF but stimulated the export of unspliced
messages through an interaction with the DExD/H-box RNA
helicase UAP56 and/or its close relative URH49 (26). Apart
from this, pUL69 has also been shown to interact with hSPT6,
a cellular factor which isimplicated in transcription elongation
and chromatin remodelling, thus suggesting a function of
pUL69 upstream of mRNA export (27).
Based on the functional similarity between the herpesviral
mRNA export factors we asked whether pUL69 directly binds
toRNAashasbeendemonstratedpreviouslyforitshomologues
in alpha- and gamma-herpesviruses. Here, we report that
pUL69 directly interacts with RNA both in vitro and in vivo.
Mapping of the domain required for RNA-binding identiﬁed
a complex arginine-rich RNA-binding domain located at the
N-terminus of the protein. Surprisingly, an RNA-binding deﬁ-
cient pUL69 mutant was still able to stimulate the cytoplasmic
accumulation of an unspliced CAT reporter RNA suggesting
that, in contrast to its homologues, RNA-binding is not a pre-
requisite for pUL69-mediated nuclear mRNA export.
MATERIALS AND METHODS
Oligonucleotides and plasmids
Oligonucleotides were obtained from Biomers.net GmbH
(Ulm, Germany) or Sigma-ARK (Darmstadt, Germany).
The sequences of oligonucleotides (50–30 sequences) used in
this study are listed in Table 1. The prokaryotic expression
plasmids for His-tagged (pHM164) and GST-tagged pUL69
(pHM185) have been described previously (23). For prokary-
otic expression of His-tagged pUL69 deletion mutants vectors
of the pQE series were used (Qiagen, Hilden, Germany)
(Figure 1A). Mutant aa1–370 was made by a PCR using
oligonucleotides pGEX5-seq and Hind370R as well as
pHM185 as a template. The fragment was inserted into the
BamHI site of vector pQE32 and the construct was designated
pHM2282. Mutant aa324–627 (pHM2283) was created by
inserting the BglII fragment of pHM164 into the BamHI-
digested vector pQE32. Mutant aa492–744 (pHM2284) was
generated by subcloning the PstI–HindIII fragment of
pHM164 into pQE31. GST-tagged aa1–50 (pHM2219) was
Table 1. Sequences of oligonucleotides used for PCR, cloning reactions and sequencing
Oligonucleotide Sequence (50 to 30)
UL69156R TATGCTCGAGAGTCGTAAGACTTACCGTAG
BamH50F GTCAGGATCCTCTCGACACGGAACGGAGCAG
BamH100F GTCAGGATCCCTCCCCTTCCACCCTCC
BamH156F GTCAGGATCCTCAACGATGACGGCGAACCG
Xho370R GTCACTCGAGGCCCACCGTTCCAGATAG
UL69aa1-16F GATCCCCATGGAGCTGCACTCACGCGGCCGTCACGACGCTCCGTCGTTATCTTCCG
UL69aa1-16R AATTCGGAAGATAACGACGGAGCGTCGTGACGGCCGCGTGAGTGCAGCTCCATGGG
EcoR31F GTCAGAATTCTGTCTGGATTACGAACC
EcoR35R GTCAGAATTCTTCGTAATCCAGACAGAAG
EcoR50F GTCAGAATTCTCGACACGGAACGGAGCAG
EcoR122R GTCAGAATTCGGTGCCCATGATGATGTG
UL69aa140-156F AATTCGCCGCGTCCGCCTCGGTGCCCCTTAACCCCCACTACGGTAAGTCTTACGACC
UL69aa140-156R TCGAGGTCGTAAGACTTACCGTAGTGGGGGTTAAGGGGCACCGAGGCGGACGCGGCG
UL69Sal35 ATACGTCGACACGGGTTCGTAATCCAG
Eco140F ATATGAATTCGCCGCGTCCGCCTCGGTG
3UL69 Xho I GATCCTCGAGTTAGTCATCCATATCATCGCT
5Ul69Bam GATCGGATCCATGGAGCTGCACTCACGCGGC
CAT5 CGTTGATATATCCCAATGGC
CAT3 GCATGATGAACCTGAATCGC
698GAP5 GTACGTCGTGGAGTCCACTG
698GAP3 TCCACCACCCTGTTGCTGTA
pGEX5-seq GGGCTGGCAAGCCACGTTTGGTG
1238 Nucleic Acids Research, 2006, Vol. 34, No. 4made by inserting the BamHI–SalI fragment of pHM185 into
the prokaryotic expression vector pGEX-5X-1 (Pharmacia
Biotech, Freiburg, Germany). Five overlapping UL69 DNA
fragments encoding polypeptides derived from amino acids 1
to 370 of pUL69 (Figure 1C) were inserted into BamHI and
XhoI sites of pGEX-5X-1. These fragments were generated
by PCR using the following oligonucleotides and pHM185
as a template (the designation of the constructs expressing
Figure1.N-terminalregionsofpUL69mediatedirectbindingtoRNAinvitro.(A)SchematicrepresentationofpUL69(aa1–744)anditstruncatedversionsthatwere
expressedasHis-tagfusionproteinsandthenusedinnorthwesternassays.Thelocalizationofthearginine-richregion(basic),thenuclearexportsignal(NES)andthe
ICP27 homology region of pUL69 are indicated. (B) His-tagged full-length (aa1–744) and truncated derivatives of pUL69 were prokaryotically expressed and
purified by metal chelate affinity chromatography. An aliquot of each preparation was analysed by SDS–PAGE and Coomassie blue staining (lanes 1–4, Co). For
the northwestern assay (NW) the same amount of proteins was separated by SDS–PAGE, blotted onto a nitrocellulose membrane, renatured and incubated with a
32P-labeled RNA probe which was generated by in vitro transcription from plasmid pHM127 coding for the IE1/2 region of HCMV. The molecular masses of the
molecular weight marker proteins are indicated at the left in kilodaltons (kDa). (C) Schematic representation of the overlapping GST-tagged polypeptides derived
from amino acids 1 to 370 of pUL69. The arginine-rich sequences within aa1–156 are indicated as R1, R2, RP and RS. Deletions of R1 and R2 in aa1–100 remove
aminoacids17–30(aa1–100DR1)andaminoacids36–50(aa1–100DR2),respectively.DeletionofRSinaa50–156removesaminoacids123–139(aa50–156DRS).
Aminoacidsequencesofthearginine-richregionsremovedfromtherespectivepUL69fragmentsareshown.(D)GSTandtheGST-taggedpolypeptidesdescribedin
(C)wereprokaryoticallyexpressedandpurifiedbyGSTaffinitychromatography.EqualamountsofeachproteinweresubjectedtoCoomassiebluestaining(Co)as
well as northwestern assay (NW) in the same manner as described in (B). (E) Electrophoretic mobility shift assays were performed by using increasing amounts of
affinity-purified GST or the GST-tagged N-terminal region of pUL69 comprising the RNA-binding domain (aa1–156). The proteins were incubated with a
32P-labeled, 150 nt RNA fragment of the UL69 gene and the RNA–protein complexes were separated by electrophoresis on a 6% native polyacrylamide gel
and detected by autoradiography.
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indicated in brackets): BamH156F and Xho370R (aa156–370,
pHM2274), pGEX5-Seq and Xho100R (aa1–100, pHM2270),
pGEX5-Seq and UL69156R (aa1–156, pHM2271), BamH50F
and Xho100R (aa50–100, pHM2272), BamH100F and
UL69156R (aa100–156, pHM2269). GST-tagged pUL69 mut-
ant aa1–100DR1 (pHM2275) expressing amino acids 1–100 of
pUL69 carrying a deletion of residues 17–30 was constructed
by ligation of three DNA fragments: oligonucleotides UL69
aa1–16FandUL69 aa1–16R wereannealed,vector pGEX-5X-
1 was digested by BamHI and XhoI and a fragment was made
by PCR using oligonucleotides EcoR31F and Xho100R as
well as pHM185 as a template followed by digestion with
EcoRI and XhoI. The ligation of these three DNA fragments
resulted in pHM2275. GST-tagged pUL69 mutant aa1–
100DR2 (pHM2276) expressing amino acids 1–100 of
pUL69 with a deletion of residues 36–50 was constructed
as follows: two fragments were made by PCR using oligonu-
cleotides pGEX5-Seq/EcoR35R and EcoR50F/Xho100R as
well as pHM185 as a template. Then, these PCR fragments
were cleaved either by BamHI and EcoRI or by EcoRI and
XhoI, respectively, and ligated with BamHI–XhoI-digested
vector pGEX-5X-1 which resulted in pHM2276. GST-
tagged pUL69 mutant aa50–156DRS (pHM2278) expresses
amino acids 50–156 of pUL69 with a deletion of residues
123–139. To construct this plasmid, oligonucleotides UL69
aa140–156F and UL69 aa140–156R were annealed and a
DNAfragmentwasmadebyPCRusingpHM185asatemplate
as well as oligonucleotides BamH50F and EcoR122R fol-
lowed by digestion with BamHI and EcoRI. The resulting
fragments were then cloned into BamHI and XhoI sites of
vector pGEX-5X-1 resulting in pHM2278. Plasmids for
prokaryotic expression of the following pUL69 in-frame dele-
tion mutants (pHM2279, 2280, 2281, 2320, 2321) were con-
structed by using vector pGEX-5X-1 in which the proteins are
N-terminally tagged with GST. DR1 (pHM2279) expresses
pUL69 with an internal deletion of amino acids 17–30. The
BamHI–SalIpartofpHM185wasreplacedbytheBamHI–SalI
fragment of pHM2275 resulting in pHM2279. DR2
(pHM2280) expresses pUL69 with an internal deletion of
amino acids 36–50. pHM2280 was constructed by replacing
the BamHI–SalI part of pHM185 with a fragment made by
PCR using oligonucleotides pGEX5-Seq and UL69Sal35 as
well as pHM185 as a template. DRS (pHM2281) encodes
pUL69 with an internal deletion of amino acids 123–139.
For this, two fragments were made by PCR using pHM185
as a template and oligonucleotides pGEX5-Seq and
EcoR122R as well as Eco140F and 3UL69XhoI. These
PCR fragments were then cleaved by BamHI and EcoRI or
EcoRI and XhoI, respectively and ligated with BamHI–XhoI-
digested vector pGEX-5X-1 which resulted in pHM2281.
DR1DRS (pHM2320) encodes pUL69 carrying deletions of
amino acids 17–30 and amino acids 123–139. pHM2320
was constructed by replacing the BamHI–SalI region of
pHM2281 with the BamHI–SalI part of pHM2275.
DR2DRS (pHM2321) contains pUL69 carrying deletions of
amino acids 36–50 and amino acids 123–139. pHM2321
was created by replacing the BamHI–SalI region of
pHM2281 with the BamHI–SalI part of pHM2276. The
N-terminally FLAG-tagged pUL69 mutants for eukaryotic
expression were produced by vectors FLAG-pcDNA3 and
FLAG-NLS-pcDNA3 (28). Mutants DR1 (pHM2322), DR2
(pHM2323), DRS (pHM2324), DR1DRS (pHM2325) and
DR2DRS (pHM2326), fused to the FLAG epitope, were con-
structed by inserting BamHI/XhoI PCR fragments of
pHM2279, pHM2280, pHM2281, pHM2320 and pHM2321,
respectively, into vector FLAG-pcDNA3. In addition, pUL69
mutants DR2 and DR2DRS were also subcloned into FLAG-
NLS-pcDNA3 to express them as FLAG and NLS fusion
proteins resulting in plasmids N-DR2 (pHM2328) and N-
DR2DRS (pHM2330). The eukaryotic expression plasmids
coding for FLAG-tagged pUL69, myc-tagged UAP56, myc-
tagged URH49, FLAG-SPT6-HA (provided by Dr H. Handa),
CFN-bGal as well as the CAT reporter plasmid pDM128/
CMV/RRE were described previously (25,26,29,30). Plasmids
pHM127, pHM149, pHM1584 and pHM2119 used in the in
vitro transcription reaction to generate RNA probes for the
RNA–protein binding assays were also described elsewhere
(26,28,31).
Protein expression and purification
Prokaryotic expression and puriﬁcation of pUL69 and its dele-
tion mutants as histidine- and GST-tagged proteins were per-
formed as described previously (25,32). To purify genuine and
mutated pUL69 as FLAG fusion proteins from mammalian
cells, 3 · 10
7 HEK 293T (human embryonic kidney) cells
were transfected with plasmids expressing the respective pro-
tein by using the standard calcium phosphate co-precipitation
method. The fusion proteins were puriﬁed from crude cell
lysates by immunoprecipitation with an anti-FLAG M2 afﬁn-
ity gel according to the manufacturer’s instructions (Sigma,
Deisenhofen, Germany). Brieﬂy, cells were harvested 48 h
after transfection and lysed in 10 ml of lysis buffer [50 mM
Tris–HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton
X-100 and 1 mM phenylmethylsulfonyl ﬂuoride (PMSF)] for
30 min at 4 C followed by centrifugation. The cleared lysate
was incubatedwith anti-FLAG M2agaroseonarotating wheel
for 4 h at 4 C. The immunoprecipitates were then washed with
TBS500 (50 mM Tris–HCl, pH7.4, 500 mM NaCl and 1 mM
PMSF) ﬁve times for 5 min and with TBS150 (50 mM
Tris–HCl, pH 7.4, 150 mM NaCl and 1 mM PMSF) three
times. The anti-FLAG M2 agarose-bound proteins were eluted
with TBS150 containing 100 mg/ml FLAG peptide. The
immunoselected proteins were analysed by SDS–PAGE fol-
lowed by Coomassie blue staining, silver staining and western
blot analysis.
In vitro transcription and RNA–protein binding assays
32P-labeled RNA probes for the northwestern blotting assays
were generated by in vitro transcription. To generate templates
for the IE1/2 and CAT RNA probes, plasmids pHM127 and
pHM2119 were linearized by cleavage with SalI. The tem-
plates for the CREB and UL82 RNA probes were prepared by
cleavage of plasmid pHM149 with HindIIIand pHM1584 with
XbaI. In vitro transcription was performed as described pre-
viously (33). Northwestern blotting assays were carried out as
described by Mears and Rice (34) with some modiﬁcations.
The puriﬁed proteins were subjected to SDS–PAGE and
electrophoretically transferred to a nitrocellulose membrane
followed by three washing steps with NW buffer (10 mM
Tris–HCl, pH 7.5, 50 mM NaCl, 1 mM EDTA, 1· Denhardt’s
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tured in situ for 12 h at 4 C in NW buffer. The membranes
were incubated at room temperature (20–25 C) for 2 h in NW
buffer containing 100 mg/ml yeast tRNA and then, after the
addition of 5 · 10
6 c.p.m. of
32P-labeled RNA probe, incuba-
tion was continued for 6 h. Then, the membranes were washed
three times in NW buffer (10 min each) at room temperature
and subsequently analysed by autoradiography.
For RNA electrophoretic mobility shift assays the afﬁnity-
puriﬁed proteins were incubated with 5 · 10
4 c.p.m. of a
150 nt
32P-labeled RNA probe for 30 min at 4 C in binding
buffer (10 mM Tris–HCl, pH 7.4, 100 mM KCl, 2 mM DTT
and 1% Triton X-100). The RNA probe was derived from the
50 end of the UL69 gene. The RNA–protein complexes were
then analysed by electrophoresis on a 6% native polyacryl-
amide gel followed by autoradiography.
Indirect immunofluorescence analysis and interspecies
heterokaryon assays
For these experiments HeLa cells were transfected by the
standard calcium phosphate co-precipitation method. Indirect
immunoﬂuorescence analysis and the interspecies het-
erokaryon assays were carried out as described earlier (25).
To detect UL69 proteins and CFN-b-Gal, a pUL69 polyclonal
serum and an anti-b-galactosidase monoclonal antibody
(Roche, Mannheim, Germany) were used in combination (25).
CAT RNA export assay and co-immunoprecipitation
analysis
For the CAT RNA export assay HEK293T cells were plated in
6-well dishes at 4.5 · 10
5 cells per dish the day before trans-
fection. DNA transfection was performed by the standard
calcium phosphate co-precipitation method using 150 ng of
the reporter plasmid pDM128/CMV/RRE and 500 ng of
the co-transfected plasmid expressing FLAG-pUL69 or the
FLAG-tagged pUL69 mutants. The cells were lysed 48 h
after transfection and CAT protein expression was analysed
by a CAT enzyme-linked immunosorbent assay according
to the manufacturer’s instructions (Roche Molecular Bio-
chemicals). Equal aliquots of each transfection were saved
for monitoring the protein expression by western blotting.
Each transfection was performed in triplicate and repeated
at least three times. Co-immunoprecipitation analyses and
detection of the co-precipitated proteins by western blotting
was performed exactly as described previously (26).
RNA immunoprecipitation
HEK 293T cells (3 · 10
6 cells) were transfected with the CAT
reporter vector pDM128/CMV/RRE along with plasmids
expressing either FLAG-UL69 or its different mutants using
the standard calcium phosphate co-precipitation method. RNA
immunoprecipitation was performed essentially as described
by Niranjanakumari et al. (35) except that no covalent cross-
linking was performed. Anti-FLAG M2 afﬁnity gel (Sigma,
Deisenhofen, Germany) was used to precipitate the respective
FLAG-tagged proteins. One-tenth of the RNA puriﬁed from
the immunoprecipitates was used as a template for RT–PCR
using the Titan One Tube RT–PCR system (Roche,
Mannheim, Germany). For ampliﬁcation of the CAT mRNA
oligonucleotides CAT5 and CAT3 were used giving rise to a
552 bp CAT fragment. Oligonucleotides 698GAP5 and
698GAP3 were used to amplify a 698 bp fragment of the
GAPDH mRNA. Ampliﬁcation conditions were optimized
to ensure that the ampliﬁcation reaction was within the
linear range. To detect any vector DNA contamination
of the immunoprecipitated RNA samples, one-tenth of the
samples was subjected to PCR without prior reverse transcrip-
tion. pDM128/CMV/RRE vector DNA (100 ng) served as a
positive control in the PCR.
RESULTS
An N-terminal domain within pUL69 mediates direct
binding to RNA in vitro
Homologues of pUL69 such as the HSV-1 protein ICP27 and
the EBV protein EB2 have been shown to bind to RNA and
this activity was found to be essential for their stimulatory
effects on mRNA export (18,22). To determine whether
pUL69 can also interact with RNA, we employed the north-
western assay since this method proved to be reliable for the
demonstration of direct RNA–protein interactions. For this,
His-tagged fusions of full-length pUL69 and of three overlap-
ping fragments covering the entire protein were expressed in
Escherichia coli and puriﬁed by afﬁnity chromatography on
Ni-NTA agarose (Figure 1A and B). Although the His-pUL69
preparations yielded major bands of the expected molecular
sizes, some additional smaller bands were visible primarily
when full-length pUL69 was puriﬁed (Figure 1B, lane 1).
Since the full-length protein and most of the smaller deriva-
tives reactedwith bothananti-Hisandananti-pUL69 antibody
in a western blot analysis these bands were most probably a
result of proteolysis during expression and/or puriﬁcation
(data not shown). Next, the puriﬁed proteins were subjected
to SDS–PAGE, transferred to a nitrocellulose membrane,
renatured in situ and incubated with
32P-labeled RNA
which was generated by in vitro transcription using a template
of the HCMV IE1/2 gene region. As shown in Figure 1B, lanes
5–8, full-length pUL69 (aa1–744), several C-terminally trun-
cated forms of full-length pUL69 as well as the N-terminal
pUL69 polypeptide (aa1–370) bound RNA. We concluded
from this experiment that the N-terminal part of pUL69 com-
prising amino acids 1–370 directly binds to RNA and hence
this domain contains the putative RNA-binding motif(s).
To further identify these motifs, we constructed a series of
deletion mutants spanning amino acids 1–370 of pUL69
(Figure 1C). The mutants were then expressed in E.coli as
GSTfusionproteins,puriﬁedbyglutathioneSepharose afﬁnity
chromatography and subjected to the northwestern assay. We
observed that the very N-terminal part of pUL69 comprising
amino acids 1–156 showed RNA-binding activity whereas a
mutant consisting of amino acids 156–370 did not (Figure 1D,
lanes 2 and 3). Furthermore, the result shown in Figure 1D,
lanes 4–7, demonstrates that the RNA-binding activity
of pUL69 can be assigned to two mutants, namely aa1–50
and aa100–156. Sequence inspection revealed that mutant
aa1–50 contains two arginine-rich sequences, termed R1
and R2 (Figure 1C, bottom left), mutant aa100–156 includes
a region containing arginines and serines that we designated
RS (Figure 1C, bottom right). Since arginines are often key
residues within RNA-binding motifs we next wanted to
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binding activity of pUL69. For this, three internal deletion
mutants lacking the indicated arginine-rich regions were
constructed (Figure 1C). As shown by northwestern assays,
a deletion of either R1 or R2 from mutant aa1–100 or a dele-
tion of RS from mutant aa50–156 resulted in a loss of the
RNA-binding activity (Figure 1D, lanes 8–10). The results of
the northwestern assay were considered speciﬁc since neither
GST alone nor GST-tagged pUL69 mutants aa156–370 or
aa50–100 bound RNA in this assay (Figure 1D, lanes 1, 2
and 6). Thus, we concluded from these experiments that the
arginine-rich N-terminus of pUL69 comprising amino
acids 1–156 is responsible for its in vitro RNA-binding
activity and this activity requires arginine-rich clusters
termed R1, R2 and RS.
To conﬁrm the UL69 RNA-binding activity with an inde-
pendent experimental approach, we performed an RNA
mobility shift assay. For this, increasing amounts of either
GST alone or GST fused to mutant aa1–156 were incubated
with
32P-labeled RNA, followed by separation of the resulting
RNA–protein complexes on a native polyacrylamide gel.
As shown in Figure 1E, retarded RNA–protein complexes
were visible only with the UL69 mutant aa1–156 but not
with GST alone. Thus, this result is in accordance with the
results obtained using the northwestern assay and conﬁrms
that the N-terminus of pUL69 encodes an RNA-binding
domain.
Arginine-rich clusters within pUL69 are
required for in vitro RNA-binding
We next wanted to specify which of the arginine-rich
sequences R1, R2 or RS contributes to the RNA-binding activ-
ity of full-length pUL69. Therefore, a series of internal dele-
tion mutants in the context of wild-type (wt) pUL69 was
generated (Figure 2A). In these mutants the arginine-rich
sequences were removed either separately (Figure 2A, DR1,
DR2, DRS) or in different combinations (Figure 2A, DR1DRS,
DR2DRS). For puriﬁcation purposes all mutants were
expressed as GST fusion proteins. As shown by Coomassie
blue staining (Figure 2B), full-length GST fusion proteins
could be detected (Figure 2B, FL-UL69); additionally, trun-
cated species of  40, 60 and 75 kDa were visible. Western
blot analysis using an anti-GST or an anti-pUL69 antibody
conﬁrmed that all fragments corresponded to C-terminally
truncated derivatives of GST-UL69 (data not shown). After
puriﬁcation, all mutants were subjected to the northwestern
assay and we observed that mutants lacking either R1 or R2
showed a substantial reduction in RNA-binding whereas the
mutant lacking RS still bound RNA (Figure 2B, lanes 2–4).
However, pUL69 mutants carrying a deletion of the RS
sequence in combination with either R1 or R2 entirely lost
their RNA-binding activity (Figure 2B, lanes 5 and 6). It is
noteworthy, that in these experiments using GST-tagged,
prokaryotically expressed proteins RNA-binding was detected
onlywith the C-terminally truncated derivatives of GST-UL69
but not with the full-length proteins. A similar observation has
also been reported for the two pUL69 homologues ICP27 (34)
and EB2 (36) and is most probably due to an incorrect refold-
ing of the full-length, GST-tagged pUL69 during renaturation.
Taken together, these experiments suggest that the arginine-
rich motifs R1 and R2 as well as the RS motif contribute to the
RNA-binding activity of the UL69 protein.
Full-length pUL69, purified from mammalian
cells, interacts with RNA in vitro but exhibits no
sequence-specificity in RNA-binding
While the herpesviral mRNA export factors ICP27 and EB2
have been shown to selectively export a set of intronless viral
mRNAs in vivo (18,37,38), they lack a distinct RNA-binding
speciﬁcity in vitro (22,34). Based on these ﬁndings we next
addressed the question whether pUL69 has any apparent
RNA-binding speciﬁcity in vitro. For this, northwestern assays
were performed using genuine and mutated pUL69 together
with four
32P-labeled RNAs that differed in both size and
Figure 2. Internal deletions within the RNA-binding domain of pUL69 impair RNA-binding in vitro.( A) Schematic diagram of GST-tagged pUL69 in-frame
deletionmutants.DR1,DR2,DRS,DR1DRS,DR2DRScarrydeletionsofaminoacids17–30,aminoacids36–50,aminoacids123–139,aminoacids17–30and123–
139, amino acids 36–50 and 123–139, respectively. (B) GST and the GST-tagged proteins described in (A) were prokaryotically expressed and purified by GST
affinity chromatography.Equalaliquotsofeach preparationwereanalysedby SDS–PAGE andCoomassiebluestaining(Co).The localizationofmolecular weight
markers is shownat the left in kilodaltons (kDa). The same amountsof proteins were tested in the northwestern assay (NW) using a
32P-labeledRNA probe derived
from the IE1/2 gene region of HCMV. FL-UL69: full-length UL69 proteins.
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probe, a 1 kb RNA corresponding to the cellular transcription
factor CREB2, a 7 kb RNA generated from the IE1/2 gene
region of HCMV and a 1.7 kb RNA derived from the UL82
gene of HCMV (Figure 3A). Since speciﬁc RNA-binding
might require posttranslational modiﬁcations that do not
occur in bacteria, all proteins used in this assay were puriﬁed
from transfected 293T cells. As shown by Coomassie blue
staining (Figure 3B), we were able to purify full-length
wild-type pUL69 as well as the two mutants DR1DRS and
DR2DRS from mammalian cells. A closer inspection revealed
the presence of three subforms of pUL69 that were originally
described for pUL69 expressed in infected ﬁbroblasts and
corresponded to differentially phosphorylated protein iso-
forms (24). When performing the northwestern assays we
noticed that full-length pUL69 (Figure 3C, pUL69) indistin-
guishably bound to every RNA tested, whereas both RNA-
binding deﬁcient mutants DR1DRS and DR2DRS did not bind
to RNA at all (Figure 3C). Thus, these results show that the
deletion of motifs R1 or R2 in combination with motif RS
also abolished the RNA-binding activity of eukaryotically
expressed pUL69. Furthermore, it is suggested that pUL69
demonstrates no obvious sequence-speciﬁcity in RNA-
binding, at least in vitro. Importantly, these data are in agree-
ment with results obtained with other herpesviral homologues
of pUL69 (22,34).
An RNA-binding deficient pUL69 mutant is able to
facilitate nuclear RNA export
Recently, we reported that pUL69 promotes the nuclear export
of unspliced mRNAs generated from a CAT reporter plasmid
(26). The UL69 protein shares this activity with some of its
herpesviral homologues such as EBV EB2 (19,22,39) and
KSHV ORF57 (20). Additionally, it has been demonstrated
that EB2 requires its RNA-binding activity to promote the
cytoplasmic accumulation of unspliced mRNA (22). To
determine whether RNA-binding is also a prerequisite for
pUL69-mediated mRNA export, a series of eukaryotic expres-
sion constructs encoding pUL69 mutants with various internal
deletions within N-terminal motifs required for RNA-binding
was generated (Figure 4A). Since the nuclear localization
signal (NLS) of pUL69 is also contained within the
N-terminus of the protein (25), we ﬁrst examined the intra-
cellular localization of the various pUL69 mutants in trans-
fected HeLa cells (Figure 4B). This revealed that all mutants
lacking the R2 region displayed a partial cytoplasmic local-
ization (Figure 4B, e, f and k, l), whereas all other mutants
accumulated in the nucleus as did the wild-type protein. This
ﬁnding is in accordance with the assumption that the R2
region overlaps with the putative bipartite NLS of pUL69.
In order to reconstitute the nuclear localization of the R2
deletion mutants the NLS of the SV40 T antigen was fused
to DR2DRS and DR2 (Figure 4B, m, n and o, p).
Next, the RNA export activity of the indicated pUL69
mutants was compared with wt pUL69 using the pDM128/
CMV/RRE reporter system (Figure 4C). In this assay,
unspliced pre-mRNA encoding an intronic CAT reporter
gene is transcribed from the reporter plasmid pDM128/
CMV/RRE. Owing to suboptimal splice sites this transcript
is a poor substrate of the spliceosome. As a consequence, the
majorityofunsplicedpre-mRNAs expressedfromthisplasmid
is retained in the nucleus yielding only traces of CAT protein
expression. However, co-transfection of pDM128/CMV/RRE
with plasmids expressing proteins that facilitate the nuclear
export of the unspliced pre-mRNAs, leads to an increase in
CAT expression (40). HEK293T cells were co-transfected
with pDM128/CMV/RRE and plasmids expressing either wt
Figure 3. pUL69, immunopurified from mammalian cells, does not show
sequence-specific binding to RNA in vitro.( A)
32P-labeled RNA probes for
northwestern blot analysis. RNA probes for the northwestern assays were
generated by in vitro transcription in the presence of [a-
32P]UTP. An aliquot
ofeachprobewasanalysedby6%urea-polyacrylamidegelelectrophoresisand
autoradiography.CAT,antisensetranscriptofthechloramphenicolacetyltrans-
ferase gene; CREB2, cellular transcription factor; IE1/2, immediate early
HCMV gene; pp71, early–late HCMV gene. (B) Immunopurification of
FLAG-tagged pUL69 and the RNA-binding deficient mutants from mamma-
lian cells. pUL69, DR1DRS and DR2DRS were expressed and purified from
HEK293T cells by anti-FLAG M2 agarose affinity chromatography. Control,
immunopurification was performed using mock transfected cells. Equal
amounts of each protein preparation were subjected to SDS–PAGE and
Coomassiebluestaining.Themolecularmassesofthemolecularweightmarker
proteins are indicated at the left in kilodaltons (kDa). (C) Northwestern assays
wereperformedbyusingthesameamountofproteinsshownin(B)andthefour
different
32P-labeled RNA probes (CAT, CREB2, IE1/2, pp71) shown in (A).
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by quantiﬁcation of CAT protein expression (Figure 4D,
lanes 1–9). In accordance with our previous results, the
amount of CAT protein was signiﬁcantly increased after
co-expression of wt pUL69, indicating that pUL69 efﬁciently
facilitates the nuclear export of unspliced pre-mRNAs
(Figure 4D, lane 2) (26). Interestingly, the deletion of the
R1 region within pUL69 abolished the RNA export activity
(Figure 4D, lanes 3 and 6) whereas a deletion of R2 or RS did
not cause any signiﬁcant defect in the RNA export activity of
pUL69 (Figure 4D, lanes 4, 5 and 7–9). Furthermore, the
RNA-binding deﬁcient pUL69 mutants DR2DRS and N-
DR2DRS could still promote the RNA export as efﬁciently
as the wild-type protein (Figure 4D, lanes 7, 9), whereas the
RNA-binding deﬁcient pUL69 mutant DR1DRS (Figure 4D,
lane 6) was inactive. This difference in the RNA export
activity of RNA-binding deﬁcient pUL69 mutants was not
due to insufﬁcient protein expression since all mutants were
expressed at comparable levels (Figure 4E). It is of note that
the pUL69 mutants which exhibited a partial cytoplasmic
localization due to the deletion of R2 (DR2 and DR2DRS)
showed a slight, however insigniﬁcant, reduction in mRNA
export activity (Figure 4D, lanes 4 and 7); when fusing these
mutants to the SV40 NLS their full RNA export activity was
restored (Figure 4D, lanes 8 and 9). In summary, we observed
that the RNA-binding deﬁcient pUL69 mutants DR2DRS
and N-DR2DRS were still able to promote the nuclear export
of unspliced RNA indicating that, in contrast to the EBV
protein EB2 (22), direct RNA interaction is not a prerequisite
for the RNA export activity of pUL69.
RNA-binding of pUL69 is dispensable for
its nucleocytoplasmic shuttling activity
Recently, we reported that the RNA export function of the
UL69 protein depends both on its nucleocytoplasmic shuttling
activity and on its ability to interact with the cellular mRNA
export factors UAP56 and/or URH49 (26). Thus, we next
aimed to exclude that the different behaviour of the two
RNA-binding deﬁcient mutants DR1DRS and DR2DRS (or
N-DR2DRS) in the mRNA export assay was due to differences
either in the ability to translocate between the nucleus and the
cytoplasm or to get access to the cellular mRNA export path-
way.First,we compared the shuttling activityofthe two RNA-
binding deﬁcient mutants using the interspecies heterokaryon
analyses. To do so, HeLa cells were co-transfected with an
expression plasmid encoding either DR1DRS or N-DR2DRS
and the CFN-bGal control plasmid that encodes a nucleus
restricted b-galactosidase. Subsequently, the transfected cells
were fused with NIH3T3 mouse ﬁbroblasts using polyethylene
Figure 4. RNA export activity of pUL69 mutants in transfected cells.
(A) Schematic diagram of FLAG-tagged pUL69 in-frame deletion mutants
used in the CAT RNA export assay. RBD represents the RNA-binding domain
of pUL69 containing arginine-rich sequences R1, R2 and RS. The binding site
of the cellular mRNA export factors UAP56 and URH49 within pUL69
overlaps with the R1 region whereas the NLS of the protein overlaps with
the R2 region. The localization of the ICP27 homology region and the NES
of pUL69 are also indicated. NLS in N-DR2 and N-DR2DRS stands for SV40
TAg NLS. (B) Immunofluorescence analysis of the subcellular localization of
the pUL69 mutants shown in (A). The proteins were transiently expressed in
HeLacells.Thetransfectedcellswerefixedbymethanol48haftertransfection
andimmunofluorescencestainingwasperformedusinganti-FLAGmonoclonal
antibody M2 and anti-mouse TRITC-conjugated secondary antibodies.
(C)SchematicrepresentationofthereporterplasmidpDM128/CMV/RREused
in the RNA export assay. The CAT reportergene is inserted into an intron. The
positions of the 50 splice donor and 30 splice acceptor sites are indicated.
CMV-P, cytomegalovirus immediate early promoter; SV40PA, SV40 late
poly(A) signal. (D) The diagram shows the relative amount of CAT proteins
expressed in HEK293Tcells following transfection with a mixture of plasmids
includingreporterplasmidpDM128/CMV/RREandplasmidsexpressingeither
FLAG-UL69oritsmutantsindicatedatthebottomofthediagramorHIV-1Rev
which was used as a positive control. The relative amount of expressed CAT
proteinisshownaspercentagerelativetothesamplewhenthereporterplasmid
was co-transfected with FLAG-UL69. (E) Western blot analysis of HEK293T
cell extracts after transfection of the FLAG-tagged proteins indicated in
(D) using an anti-FLAG antibody.
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subcellular localization of the respective proteins was assessed
by indirect immunoﬂuorescence analysis. As shown in
Figure 5A and B, mutants DR1DRS and N-DR2DRS were
found to be present in both murine and human nuclei whereas
CFN-b-Gal was detected exclusively in the human nuclei.
Therefore, both RNA-binding deﬁcient UL69 mutants were
selectively and comparably transported from the transfected
HeLacellnucleusintothecytoplasmandsubsequentlyintothe
murine nucleus and thus were fully capable of nucleocyto-
plasmic shuttling. We concluded from this set of experiments
that (i) the removal of the R1, R2 or RS motif from pUL69
does not interfere with its shuttling activity and that (ii)
nucleocytoplasmic shuttling of pUL69 is not dependent on
its RNA-binding activity.
Discordant interaction of RNA-binding deficient
pUL69 mutants with the cellular mRNA
export factors UAP56 and URH49
Next, we asked whether the observed discrepancy in the RNA
export activity of the two RNA-binding deﬁcient pUL69
mutants could be explained by an impaired binding capacity
of DR1DRS to the cellular mRNA export factors UAP56 or
URH49. This idea is based on our previous observation that
the UAP56/URH49-binding motif could be mapped by yeast
two-hybrid experiments to the N-terminal amino acids 18–30
of pUL69 (26). The DR1 mutants carry a deletion which com-
prises amino acids 17–31 and hence lack the putative UAP56/
URH49-binding motif entirely. Thus, in order to clarify
whether the observed discrepancy in the RNA export activity
is due to impaired binding to UAP56 or URH49, immunopre-
cipitation experiments were performed. For this 293T cells
were co-transfected with expression vectors encoding either
myc-tagged UAP56 or myc-tagged URH49 together with plas-
mids expressing the FLAG-tagged proteins UL69, DR1DRS or
DR2DRS (Figure 6A). Subsequently, immunoprecipitations
were carried out from whole cell extracts using an anti-myc
antibody and the co-immunoprecipitated proteins were
detected by western blot analysis using an anti-FLAG anti-
body. We found that both myc-UAP56 and myc-URH49 failed
to co-immunoprecipitate the DR1DRS mutant (Figure 6A,
compare lanes 3, 6 and 10, 13) while wt UL69 and the
DR2DRS mutant were precipitated efﬁciently (Figure 6A,
compare lanes 2, 4, 5, 7 and 9, 11, 12, 14). To exclude that
the overall structure of one of the pUL69 mutants was
seriously affected by the internal deletions, we also examined
the interaction of the mutants with an additional cellular
pUL69 interaction partner, the transcription elongation factor
hSPT6 (Figure 6B). Hence, 293T cells were co-transfected
with an expression vector for FLAG- and HA-tagged
SPT6 (Figure 6B, F-Spt6-HA) and expression vectors
encoding either pUL69 or one of the RNA-binding deﬁcient
mutants as FLAG fusion proteins. The immunoprecipitations
were carried out using an anti-HA antibody and co-
immunoprecipitated proteins were detected in a western
blot analysis using an anti-FLAG antibody. As demonstrated,
both RNA-binding mutants could still interact with the pUL69
interaction partner hSPT6 (Figure 6B, compare lanes 2–4
and 6–8), indicating that the 3D structure of the internal dele-
tion mutants was not signiﬁcantly affected due to the deletion
of R1. Taken together, these experiments indicate that, as
expected, binding of pUL69 to UAP56 or URH49 is crucial
for the pUL69-mediated export of a reporter mRNA, while
RNA-binding ofpUL69 appearsto be dispensable. In addition,
Figure 5. Nucleocytoplasmic shuttling activity of the RNA-binding deficient
pUL69 mutants. Heterokaryons were generated by fusion of HeLa cells trans-
fected with the control plasmid CFN-b-Gal and either FLAG-tagged DR1DRS
or N-DR2DRS and NIH3T3 mouse cells. Cells were then immunostained both
withan anti-UL69polyclonalserum and a monoclonalantibodyagainst b-Gal.
Murinenucleiareindicatedbyarrows.Thephasecontrastimages(phase)show
theheterokaryons.Hoechst,stainingwithHoechst33258.(A)Nucleocytoplas-
micshuttlingoftheRNA-bindingdeficientpUL69mutantDR1DRSand(B)the
RNA-binding deficient pUL69 mutant N-DR2DRS.
Figure 6. In vivo interaction of the RNA-binding deficient pUL69 mutants
withcellularproteinsUAP56andURH49aswellashSPT6.(A)Analysisofthe
interaction between RNA-binding deficient pUL69 mutants (DR1DRS,
DR2DRS) and the cellular mRNA export factors UAP56 and URH49 by co-
immunoprecipitation experiments. HEK293T cells were transfected with plas-
mids coding for FLAG-UL69 (pUL69, lanes 1, 2, 5, 8, 9 and 12) or FLAG-
tagged RNA-binding mutants (DR1DRS, lanes 3, 6, 10 and 13 and DR2DRS,
lanes 4, 7, 11 and 14) together with plasmids expressing either myc-UAP56
(mUAP56, lanes 2–4 and 9–11) or myc-URH49 (mURH49, lanes 5–7 and 12–
14).Theamountofproteinin theinputwasanalysedbywesternblotting(lanes
1–7). Immunoprecipitations were performed with anti-myc monoclonal anti-
body and the co-immunoprecipitated proteins were detected by western blot
analysis using anti-FLAG antibody M2 (upper panel) or an anti-myc antibody
(lowerpanel)(lanes8–14).(B)InteractionoftheRNA-bindingdeficientpUL69
mutantswiththecellulartranscriptionelongationfactorSPT6.FLAG-andHA-
tagged SPT6 (FLAG-SPT6-HA) was co-transfected with either FLAG-UL69
(pUL69, lanes 1, 2, 5 and 6) or the RNA-binding deficient pUL69 mutants
(DR1DRS, lanes 3 and 7 and DR2DRS, lanes 4 and 8) into HEK293T cells. The
amount of protein in the input was analysed by western blotting using anti-
FLAG antibody M2 (lanes 1–4). Immunoprecipitations were performed by
using anti-HA polyclonal antibody followed by western blot analysis of the
co-immunoprecipitated proteins using anti-FLAG antibody M2 (lanes 5–8).
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pUL69 to UAP56 or URH49 is not bridged via RNA.
pUL69 associates with unspliced CAT mRNA in vivo
Internal deletions within the RNA-binding domain of pUL69
resulted in three different types of mutants depicted in
Figure 7A: (i) a UAP56/URH49-binding deﬁcient mutant
termed DR1, (ii) an RNA-binding deﬁcient mutant termed
DR2DRS and (iii) mutant DR1DRS incapable of both
UAP56/URH49- and RNA-binding. Although it was con-
ﬁrmed with both prokaryotically and eukaryotically expressed
proteins that DR1DRS and DR2DRS are incapable of inter-
acting with RNA in vitro, we considered the possibility that
these mutants might still be able to bind RNA under in vivo
conditions. In order to investigate this, an RNA-
immunoprecipitation analysis was performed. HEK293T
cells were transfected with plasmids encoding the FLAG-
tagged proteins pUL69, DR1, DR2DRS or DR1DRS along
with the CAT reporter plasmid pDM128/CMV/RRE
(Figure 7A). Cell lysates were prepared 48 h after transfection
and western blotting was performed to ensure that all trans-
fected proteins were expressed at a comparable level
(Figure 7B, lanes 1–5). Additionally, RT–PCR was used to
detect the amount of co-transfected CAT mRNA in each of
these cell lysates (Figure 7C, lanes 1–5; CAT). In parallel, an
anti-FLAG immunoprecipitation was performed followed by
the extraction of bound RNAs from the immunoprecipitates.
Subsequently, the presence of unspliced CAT mRNA in the
immunoprecipitates was monitored by RT–PCR using primers
with speciﬁcity for the intronic CAT sequence (Figure 7C,
lanes 6–10). As expected, CAT mRNA could not be ampliﬁed
from animmunoprecipitatederived fromcells transfected with
vector pcDNA3 (Figure 7B and C, compare lane 6). However,
after precipitation of pUL69 we could easily detect co-
precipitated CAT mRNA (Figure 7C, lane 7) demonstrating
that CAT mRNA associates with pUL69 within the transfected
cells.Incontrast,whenthetwoRNA-bindingdeﬁcientmutants
DR2DRS and DR1DRS were immunoprecipitated, coprecipi-
tating CAT mRNA was barely or not detectable (Figure 7C,
lanes 9 and 10) emphasizing the importance of the arginine-
rich regions for in vivo RNA-binding of pUL69.
To investigate whether the interaction of pUL69 with
the cellular mRNA export factors UAP56 and URH49 con-
tributes to the in vivo association of pUL69 with CAT mRNA,
the DR1 mutant lacking the UAP56/URH49-binding site was
also tested in the RNA-immunoprecipitation analyis
(Figure 7C, lane 8). It is shown that a signiﬁcantly reduced
amount of CAT mRNA could be immunoprecipitated by the
DR1 mutant (Figure 7C, lane 8). This ﬁnding is consistent with
our in vitro results which also revealed a reduced RNA-
binding activity for DR1 in comparison to wt pUL69. This
could indicate that the R1 motif might be involved in directly
contacting RNA in vivo as well. However, the fact that mutant
DR2DRS, which was found to be inactive in in vitro RNA-
binding assays, could be co-immunoprecipitated with low
amounts of CAT mRNA, whereas the RNA- and UAP56-
binding deﬁcient mutant DR1DRs was negative suggests
that the association with UAP56 contributes to the in vivo
association of pUL69 with CAT mRNA (Figure 7C, lanes
9 and 10).
Finally, we asked whether pUL69 binds non-speciﬁcally to
any arbitrary RNA within the transfected cells. Therefore,
we analysed the immunoprecipitates for the presence of
GAPDH mRNA, an abundant cellular transcript. Although
GAPDH mRNA was easily detectable in total cell extracts
(Figure 7C, lanes 1–5; GAPDH) it was not present in
pUL69 immunoprecipitates (Figure 7C, lanes 6–10;
GAPDH), demonstrating that the association of CAT
mRNA with pUL69 in vivo can not be considered to be com-
pletely non-speciﬁc. In summary, we conclude from these
experiments that pUL69 associates with unspliced CAT
mRNA within living cells and that this pUL69–RNA complex
can be disrupted by deleting distinct arginine-rich regions
which have also been shown to mediate RNA-binding of
pUL69 in in vitro assays.
DISCUSSION
In this study we demonstrate that the beta-herpesviral protein
encoded by the open reading frame UL69 of HCMV is capable
Figure 7. Association of pUL69 with CAT mRNA in vivo.( A) Schematic
diagram of FLAG-tagged pUL69 and its in-frame deletion mutants used in
the RNA immunoprecipitations. RBD, RNA-binding domain of pUL69 con-
taining arginine-rich sequences R1, R2 and RS; UAP56, binding site of the
cellular mRNA export factors UAP56 and URH49 within pUL69. The locali-
zation of the ICP27 homology region and the NES of pUL69 is indicated as
well as the capacity of pUL69 and of the mutants to bind to UAP56/URH49
and to RNA in vitro.( B) Immunoprecipitation of pUL69 and the mutants from
HEK293T cells. Cells were transfected with pDM128/CMV/RRE along with
vectorsexpressingeitherpUL69(lanes2and7)orthemutants(DR1,lanes3and
8; DR2DRS, lanes 4 and 9; DR1DRS, lanes 5 and 10). The amount of protein in
theinputwasanalysedbywesternblottingusingananti-FLAGantibody(lanes
1–5).Immunoprecipitationwasperformedbyananti-FLAGantibodyfollowed
by a western blot analysis of the precipitated proteins using an anti-FLAG
antibody (lanes 6–10). (C) Co-immunoprecipitation of CAT mRNA bound
by pUL69 and the mutants in vivo. RNA was extracted from cell extracts
and the immunoprecipitates described in (B). Thereafter, RT–PCR was per-
formedusingsequence-specificprimersfortheintronicCATreportergeneand
GAPDH. The amount of both CAT and GAPDH mRNA was evaluated by
RT–PCR both in cell extracts (input, lanes 1–5) and in the immunoprecipitates
(lanes 6–10). Control PCRs were also performed to detect any reporter vector
contamination of the RNA samples used for RT–PCR (PCR, 1–10).
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its homologous proteins in alpha- and gamma-herpesviruses
(18,22,34,41). The RNA-binding activity could be assigned to
the N-terminus of pUL69 and was further narrowed down to
three arginine-rich motifs termed R1, R2 and RS. Both R1 and
R2 resemble arginine-rich RNA-binding motifs (ARMs)
which have been identiﬁed in several viral RNA-binding pro-
teins like the HIV-1 Rev and Tat proteins, the phage l No r
the hepatitits delta virus (HDV) HDAg proteins (Figure 8A)
(42–45). The ARM sequence is short (10–20 amino acids) and
characterizedby a preponderance ofarginine residues butlittle
other sequence similarity suggesting that ARMs have arisen
independently throughout phylogeny (46). With regard to
herpesviruses, it has been demonstrated that RNA-binding
of the EBV mRNA export factor EB2 also involves an
ARM motif (22). In contrast, RNA-binding of HSV-1
ICP27 is mediated by an RGG box motif in vitro and
in vivo (18,34,41) but three additional KH-like RNA-binding
domains were proposed to be of additional importance for
interacting with a subset of mRNAs in vivo (47,48). For
pUL69, R1 and R2 together appear to be required for
strong RNA-binding in vitro suggesting that they may
function as a bipartite ARM which was ﬁrst identiﬁed in
the HDV delta antigen (44). Deletion of RS in combination
with either R1 or R2 abolished the RNA-binding activity
of pUL69 in vitro and disrupted the efﬁcient association
with RNA in vivo.
Although one might assume that protein domains with
numerous arginine residues bind RNA non-speciﬁcally,
sequence-speciﬁc interactions were demonstrated for the
majority of ARM containing proteins investigated so far
which includes the HIV-1 proteins Rev and Tat or the
phage l N protein (42,43,45). However, the RNA target
sequences of ARM proteins appear to be complex consisting
of secondary structures such as stem–loops (phage l N pro-
tein), internal loops (HIV-1 mRNA export factor Rev), bulges
(HIV-1 Tat antiterminator protein) or rod-like structures
(hepatitis D virus HDAg protein) (49,50). In addition, it
was shown that some ARMs exhibit promiscuity in RNA-
binding which was described as ‘chameleon-like’ behaviour
(51). For instance, the Jembrana disease virus (JDV) Tat
protein can bind both the BIV and HIV-1 TAR RNAs via
different secondary protein structures indicating that RNA
architectures can dictate the folds of ARM peptides (51).
As shown by our in vitro RNA-binding assays we were not
able to obtain evidence for sequence-speciﬁc RNA-binding by
pUL69 although we used full-length protein puriﬁed from
mammalian cells thus representing the three differentially
phosphorylated isoforms of pUL69 (Figure 3). This is similar
to results obtained for ICP27 (34) and EB2 (22). Nevertheless,
several lines of evidence suggest the existence of a mechanism
that confers speciﬁcity to the recognition of RNA by these
herpesviral RNA export factors, at least in vivo: (i) by UV-
crosslinking experiments using virus infected cells it was
shown that ICP27 selectively binds to HSV-1 intronless
RNAs but not to HSV-1 RNAs that undergo splicing (18);
(ii) EB2 selectively mediates the nuclear export of mRNAs
in vivo as demonstrated for a set of EBV replication gene
mRNAs and most of the late mRNAs (38,52); and (iii) we
could show in this study by RNA-immunoprecipitation
experiments that pUL69 efﬁciently associates with CAT
mRNA but not with the cellular transcript for GAPDH.
At present, it is not clear which factors determine the
selective association of pUL69 and its homologues with
mRNA in vivo. Since the herpesviral RNA export factors
interact with several viral and cellular proteins, it is conceiv-
able that some of these interactions may be needed to confer
speciﬁcity to RNA recognition. In addition, the secondary
structure of RNA may be crucial for its correct recognition
which could be altered by proteins associated with the mRNAs
in cells. Further detailed investigations will be required in
order to clarify these points.
We have recently shown that pUL69 facilitates the nuclear
export of unspliced mRNA from a CAT reporter gene (26).
Consequently, we investigated whether RNA-binding of
pUL69 would be required for its ability to promote RNA
export. Surprisingly, discordant results were obtained when
we analysed the activity of two different RNA-binding deﬁ-
cient mutants of pUL69: while mutant DR2DRS could still
promote the nuclear export of unspliced CAT reporter
RNA, mutant DR1DRS was inactive. In addition, we observed
that mutant DR1, which was still able to bind RNA, could also
no longer stimulate mRNA export. The discrepancy in the
RNA export activity of these mutants turned out to be due
to deletion of the binding site for the cellular RNA export
factors UAP56 and URH49, which overlaps with the R1
Figure 8. pUL69 contains two RNA-binding ARMs which can be found at the
non-conserved N-teminus of the protein. (A) The ARMs of pUL69 (UL69-R1
and -R2) in comparison with conserved ARMs in representative viral RNA-
binding proteins. The arginine residues are highlighted. Abbreviations: HIV
Rev,theviralmRNAexportfactorofhumanimmunodeficiencyvirus;HIVTat,
HIV antiterminator protein; lN, bacteriophage l antiterminator N protein;
HDAg ARM1 and ARM2, two ARMs in hepatitis delta antigen of hepatitis
delta virus. (B) Schematic comparative diagram of the functional domain
organization at the N-terminus of pUL69 and its counterparts from a, b and
g-herpesvirussubfamilies.ICP27,viralmRNAexportfactorofHSV-1fromthe
a-subfamily. EB2, viral mRNA export factor of EBV from the g-subfamily.
Domains supposed to be important for their function as viral mRNA export
factorsareshown.NES,nuclearexportsignal;NLS,nuclearlocalizationsignal;
RBD, RNA-binding domain; REF, TAP and UAP56, the binding sites of the
cellular mRNA export factors REF, TAP and UAP56/URH49, respectively,
within the viral proteins. KH1, KH2 and KH3, regions with homology to KH
RNA-bindingmotifs.OtherdomainsarealsoshownsuchasNuLSfornucleolar
localization signal and ICP27 homology region.
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tion that the binding of UAP56 or URH49 to pUL69 is a
prerequisite for pUL69-mediated RNA export (26). For
DR2DRS we detected a residual RNA-binding activity in
vivo by RNA-immunoprecipitation analysis but this might
be due to an indirect association with RNA via its interaction
with the cellular mRNA export factors UAP56 or URH49.
This is also supported by the observation that the UAP56/
URH49-binding deﬁcient mutant DR1DRS is totally devoid
of RNA-binding both in vitro and in vivo. In summary, we
conclude from these results that direct RNA-binding by
pUL69 is dispensable for its activity to stimulate the nuclear
export of unspliced CAT mRNA.
This ﬁnding seems to be contradictory to previous assump-
tions that the RNA-binding of herpesviral mRNA export fac-
tors is essential for their function, since it was proposed that
both ICP27 and EB2 bind directly to speciﬁc herpesviral
RNAs, ultimately recruiting these transcripts to the cellular
mRNA export pathway via interacting with REF (15,17,19).
However, it has to be mentioned that EB2 interacts with REF
in vivo in an RNase sensitive manner since RNase treatment
completely abolished the immunoprecipitation of EB2 with
REF and TAP from both transfected and infected cells (19).
This was also observed for ICP27 (19) although other studies
reported on an RNase insensitive interaction with REF (15).
This may suggest that RNA is a stabilizing component of the
complex between REF and EB2 or ICP27 within cells and
contributes to the RNA export activity of these factors. In
contrast, binding of pUL69 to UAP56 and URH49 has been
shown previously to be insensitive to RNase treatment (26)
which is also supported by results from this study demon-
strating that the RNA-binding deﬁcient pUL69 mutant
DR2DRS is still able to interact with UAP56 or URH49.
Since the UAP56/URH49-binding site overlaps with the
RNA-binding domain within pUL69 (Figure 8B), it is even
conceivable that RNA-binding and UAP56/URH49-binding
might be mutually exclusive as has been reported for the
inﬂuenza virus nucleocapsid protein (NP) (53). For inﬂuenza
virus NP it was shown that UAP56 facilitates the formation of
the NP–RNA complexsuggesting that UAP56 may functionas
a chaperon for loading of free NP onto RNA thus leading to
enhanced inﬂuenza virus RNA synthesis (53). It is tempting
to speculate that the cellular mRNA export factor UAP56
could also function as a carrier to transfer pUL69 onto the
pre-mRNA incorporating it into the nascent mRNP where
pUL69 may become a stable component of mRNPs by inter-
acting with additional mRNP proteins. Further studies are
required to clarify this hypothesis.
Furthermore, RNA-binding of pUL69 might play a role for
the packaging of RNAs into HCMV virions. A subset of viral
and cellular mRNAs has been shown previously to be incor-
porated into HCMV virions by an as yet unknown mechanism
(54,55). Since the UL69 protein is also contained within viral
particles it is conceivable that its RNA-binding activity might
contribute to the packaging of RNAs into virions.
In summary, we identiﬁed and characterized a complex,
arginine-rich RNA-binding domain within the N-terminus
of pUL69 which directly interacts with RNA in a sequence
non-speciﬁc manner in in vitro assays but may selectively
associate with RNA in vivo. Additional studies using recom-
binant HCMVs which express RNA-binding deﬁcient
pUL69 mutants will be required to further clarify the role
of pUL69 RNA-binding for viral replication.
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